NCT00697879: Safety Study of the Histone Deacetylase Inhibitor, CHR-3996, in Patients With Advanced Solid Tumours |
|
|
| Completed | 1 | 40 | Europe | CHR-3996, Histone deacetylase inhibitor, HDACi | Chroma Therapeutics | Solid Tumor | 11/10 | 11/11 | | |
NCT06302140: A Mass Balance Study of [14C]-Nanatinostat and Relative Bioavailability Study of Nanatinostat in Patients With Advanced Cancers |
|
|
| Recruiting | 1 | 14 | Europe | [14C]-Nanatinostat, Nanatinostat (free base) tablets in combination with Valganciclovir, Nanatinostat mesylate tablets in combination with Valganciclovir, Single-agent Nanatinostat (free base) tablets | Viracta Therapeutics, Inc. | Advanced Cancer | 02/25 | 10/25 | | |
